PACAX
Price
$10.58
Change
+$0.03 (+0.28%)
Updated
Apr 29 closing price
Net Assets
568.22M
SWLRX
Price
$9.33
Change
+$0.02 (+0.21%)
Updated
Apr 29 closing price
Net Assets
58.26M
Ad is loading...

PACAX vs SWLRX

Header iconPACAX vs SWLRX Comparison
Open Charts PACAX vs SWLRXBanner chart's image
Putnam Dynamic Asset Allocation Cnsrv A
Price$10.58
Change+$0.03 (+0.28%)
VolumeN/A
Net Assets568.22M
Schwab® Monthly Income Income Payout
Price$9.33
Change+$0.02 (+0.21%)
VolumeN/A
Net Assets58.26M
PACAX vs SWLRX Comparison Chart
Loading...
View a ticker or compare two or three
VS
PACAX vs. SWLRX commentary
Apr 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PACAX is a Buy and SWLRX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
PACAX has more cash in the bank: 568M vs. SWLRX (58.3M). SWLRX pays higher dividends than PACAX: SWLRX (4.84) vs PACAX (3.51). PACAX was incepted earlier than SWLRX: PACAX (31 years) vs SWLRX (17 years). PACAX (1.00) is less costly to investors than SWLRX (0.30). PACAX is a more actively managed with annual turnover of: 372.00 vs. SWLRX (8.00). PACAX (0) and SWLRX (0) have matching initial minimum investment requirements. SWLRX annual gain was more profitable for investors over the last year : 7.88 vs. PACAX (6.18). PACAX return over 5 years is better than : 9.87 vs. SWLRX (6.42).
PACAXSWLRXPACAX / SWLRX
Total Expense Ratio1.000.16625%
Annual Report Gross Expense Ratio1.000.30333%
Fund Existence31 years17 years-
Gain YTD0.5812.60722%
Front Load6%N/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets568M58.3M974%
Annual Yield % from dividends3.514.8473%
Returns for 1 year6.187.8878%
Returns for 3 years9.678.97108%
Returns for 5 years9.876.42154%
Returns for 10 years16.4316.8797%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GEQIX14.260.09
+0.64%
Glenmede Equity Income
IYBIX23.100.14
+0.61%
Macquarie Balanced Fund Class I
LGOPX21.97N/A
N/A
Lord Abbett Growth Opportunities P
MDFSX7.26N/A
N/A
Manning & Napier Disciplined Value S
VGRTX75.68N/A
N/A
JPMorgan US Value R2